nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—JAK2—ulcerative colitis	0.607	1	CbGaD
Ruxolitinib—RET—enteric nervous system—ulcerative colitis	0.0144	0.146	CbGeAlD
Ruxolitinib—Myelosuppression—Mercaptopurine—ulcerative colitis	0.00313	0.0438	CcSEcCtD
Ruxolitinib—PRKG2—smooth muscle tissue—ulcerative colitis	0.00285	0.0289	CbGeAlD
Ruxolitinib—Tuberculosis—Dexamethasone—ulcerative colitis	0.00265	0.0371	CcSEcCtD
Ruxolitinib—Tuberculosis—Betamethasone—ulcerative colitis	0.00265	0.0371	CcSEcCtD
Ruxolitinib—Tuberculosis—Prednisone—ulcerative colitis	0.00231	0.0323	CcSEcCtD
Ruxolitinib—PRKG2—digestive system—ulcerative colitis	0.00225	0.0228	CbGeAlD
Ruxolitinib—PLK1—Calcipotriol—Cholecalciferol—ulcerative colitis	0.00221	1	CbGdCrCtD
Ruxolitinib—PLK1—lymphoid tissue—ulcerative colitis	0.00205	0.0207	CbGeAlD
Ruxolitinib—PLK1—digestive system—ulcerative colitis	0.00202	0.0205	CbGeAlD
Ruxolitinib—Myelosuppression—Azathioprine—ulcerative colitis	0.00187	0.0261	CcSEcCtD
Ruxolitinib—JAK1—epithelium—ulcerative colitis	0.0017	0.0173	CbGeAlD
Ruxolitinib—PRKG2—liver—ulcerative colitis	0.00168	0.017	CbGeAlD
Ruxolitinib—JAK1—smooth muscle tissue—ulcerative colitis	0.00164	0.0166	CbGeAlD
Ruxolitinib—PRKCE—liver—ulcerative colitis	0.00157	0.0159	CbGeAlD
Ruxolitinib—MARK2—digestive system—ulcerative colitis	0.00153	0.0155	CbGeAlD
Ruxolitinib—PLK1—liver—ulcerative colitis	0.00151	0.0153	CbGeAlD
Ruxolitinib—RPS6KA6—liver—ulcerative colitis	0.00151	0.0153	CbGeAlD
Ruxolitinib—DAPK3—smooth muscle tissue—ulcerative colitis	0.00147	0.0149	CbGeAlD
Ruxolitinib—ROCK1—epithelium—ulcerative colitis	0.00146	0.0149	CbGeAlD
Ruxolitinib—ROCK1—smooth muscle tissue—ulcerative colitis	0.00141	0.0143	CbGeAlD
Ruxolitinib—BMPR2—smooth muscle tissue—ulcerative colitis	0.00137	0.0139	CbGeAlD
Ruxolitinib—JAK3—lymphoid tissue—ulcerative colitis	0.00132	0.0134	CbGeAlD
Ruxolitinib—JAK1—lymphoid tissue—ulcerative colitis	0.00131	0.0133	CbGeAlD
Ruxolitinib—JAK3—digestive system—ulcerative colitis	0.0013	0.0132	CbGeAlD
Ruxolitinib—PLK4—lymphoid tissue—ulcerative colitis	0.0013	0.0132	CbGeAlD
Ruxolitinib—JAK1—digestive system—ulcerative colitis	0.00129	0.0131	CbGeAlD
Ruxolitinib—DCLK1—digestive system—ulcerative colitis	0.00129	0.0131	CbGeAlD
Ruxolitinib—PLK3—liver—ulcerative colitis	0.00126	0.0127	CbGeAlD
Ruxolitinib—STK16—lymphoid tissue—ulcerative colitis	0.00123	0.0125	CbGeAlD
Ruxolitinib—HIPK2—lymphoid tissue—ulcerative colitis	0.00122	0.0124	CbGeAlD
Ruxolitinib—STK16—digestive system—ulcerative colitis	0.00121	0.0123	CbGeAlD
Ruxolitinib—HIPK2—digestive system—ulcerative colitis	0.00121	0.0123	CbGeAlD
Ruxolitinib—CAMK1—liver—ulcerative colitis	0.00118	0.0119	CbGeAlD
Ruxolitinib—CLK2—lymphoid tissue—ulcerative colitis	0.00116	0.0118	CbGeAlD
Ruxolitinib—Herpes zoster—Azathioprine—ulcerative colitis	0.00116	0.0163	CcSEcCtD
Ruxolitinib—ROCK1—lymphoid tissue—ulcerative colitis	0.00113	0.0114	CbGeAlD
Ruxolitinib—Contusion—Budesonide—ulcerative colitis	0.00112	0.0157	CcSEcCtD
Ruxolitinib—ROCK1—digestive system—ulcerative colitis	0.00111	0.0113	CbGeAlD
Ruxolitinib—MKNK2—epithelium—ulcerative colitis	0.00111	0.0113	CbGeAlD
Ruxolitinib—MAP3K7—smooth muscle tissue—ulcerative colitis	0.0011	0.0112	CbGeAlD
Ruxolitinib—DYRK1A—lymphoid tissue—ulcerative colitis	0.0011	0.0112	CbGeAlD
Ruxolitinib—BMPR2—lymphoid tissue—ulcerative colitis	0.0011	0.0111	CbGeAlD
Ruxolitinib—TYK2—smooth muscle tissue—ulcerative colitis	0.00108	0.011	CbGeAlD
Ruxolitinib—RET—epithelium—ulcerative colitis	0.00108	0.011	CbGeAlD
Ruxolitinib—BMPR2—digestive system—ulcerative colitis	0.00108	0.011	CbGeAlD
Ruxolitinib—MKNK2—smooth muscle tissue—ulcerative colitis	0.00107	0.0108	CbGeAlD
Ruxolitinib—IRAK1—smooth muscle tissue—ulcerative colitis	0.00107	0.0108	CbGeAlD
Ruxolitinib—TAOK2—liver—ulcerative colitis	0.00106	0.0107	CbGeAlD
Ruxolitinib—JAK2—epithelium—ulcerative colitis	0.00102	0.0104	CbGeAlD
Ruxolitinib—JAK2—smooth muscle tissue—ulcerative colitis	0.000986	0.01	CbGeAlD
Ruxolitinib—CAMK2G—digestive system—ulcerative colitis	0.000969	0.00982	CbGeAlD
Ruxolitinib—JAK1—liver—ulcerative colitis	0.000964	0.00978	CbGeAlD
Ruxolitinib—CAMK1D—liver—ulcerative colitis	0.000941	0.00954	CbGeAlD
Ruxolitinib—PHKG2—liver—ulcerative colitis	0.000936	0.00949	CbGeAlD
Ruxolitinib—STK16—liver—ulcerative colitis	0.000905	0.00918	CbGeAlD
Ruxolitinib—HIPK2—liver—ulcerative colitis	0.0009	0.00913	CbGeAlD
Ruxolitinib—MAP3K2—lymphoid tissue—ulcerative colitis	0.000891	0.00903	CbGeAlD
Ruxolitinib—Pancytopenia—Mercaptopurine—ulcerative colitis	0.000876	0.0122	CcSEcCtD
Ruxolitinib—TYK2—lymphoid tissue—ulcerative colitis	0.000866	0.00879	CbGeAlD
Ruxolitinib—DAPK3—liver—ulcerative colitis	0.000865	0.00877	CbGeAlD
Ruxolitinib—CLK2—liver—ulcerative colitis	0.000857	0.00869	CbGeAlD
Ruxolitinib—TYK2—digestive system—ulcerative colitis	0.000856	0.00868	CbGeAlD
Ruxolitinib—MKNK2—lymphoid tissue—ulcerative colitis	0.000855	0.00867	CbGeAlD
Ruxolitinib—MKNK2—digestive system—ulcerative colitis	0.000845	0.00856	CbGeAlD
Ruxolitinib—RET—lymphoid tissue—ulcerative colitis	0.000834	0.00846	CbGeAlD
Ruxolitinib—ROCK1—liver—ulcerative colitis	0.00083	0.00842	CbGeAlD
Ruxolitinib—RET—digestive system—ulcerative colitis	0.000824	0.00835	CbGeAlD
Ruxolitinib—Weight increased—Nicotine—ulcerative colitis	0.000813	0.0114	CcSEcCtD
Ruxolitinib—DYRK1A—liver—ulcerative colitis	0.00081	0.00821	CbGeAlD
Ruxolitinib—BMPR2—liver—ulcerative colitis	0.000806	0.00818	CbGeAlD
Ruxolitinib—JAK2—lymphoid tissue—ulcerative colitis	0.000788	0.00799	CbGeAlD
Ruxolitinib—JAK2—digestive system—ulcerative colitis	0.000778	0.00789	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Mercaptopurine—ulcerative colitis	0.000778	0.0109	CcSEcCtD
Ruxolitinib—NUAK2—liver—ulcerative colitis	0.000771	0.00782	CbGeAlD
Ruxolitinib—Epistaxis—Nicotine—ulcerative colitis	0.000751	0.0105	CcSEcCtD
Ruxolitinib—CAMK2G—liver—ulcerative colitis	0.000722	0.00732	CbGeAlD
Ruxolitinib—BMP2K—liver—ulcerative colitis	0.000722	0.00732	CbGeAlD
Ruxolitinib—LRRK2—liver—ulcerative colitis	0.000715	0.00725	CbGeAlD
Ruxolitinib—TAOK3—lymphoid tissue—ulcerative colitis	0.000693	0.00702	CbGeAlD
Ruxolitinib—TAOK3—digestive system—ulcerative colitis	0.000684	0.00694	CbGeAlD
Ruxolitinib—MAP3K2—liver—ulcerative colitis	0.000655	0.00665	CbGeAlD
Ruxolitinib—Contusion—Hydrocortisone—ulcerative colitis	0.00065	0.00908	CcSEcCtD
Ruxolitinib—MAP3K7—liver—ulcerative colitis	0.000649	0.00658	CbGeAlD
Ruxolitinib—Malnutrition—Mercaptopurine—ulcerative colitis	0.000643	0.00898	CcSEcCtD
Ruxolitinib—TYK2—liver—ulcerative colitis	0.000637	0.00647	CbGeAlD
Ruxolitinib—MKNK2—liver—ulcerative colitis	0.000629	0.00638	CbGeAlD
Ruxolitinib—IRAK1—liver—ulcerative colitis	0.000629	0.00638	CbGeAlD
Ruxolitinib—Flatulence—Nicotine—ulcerative colitis	0.000614	0.00857	CcSEcCtD
Ruxolitinib—Anaemia—Mercaptopurine—ulcerative colitis	0.000594	0.0083	CcSEcCtD
Ruxolitinib—JAK2—liver—ulcerative colitis	0.00058	0.00588	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Mesalazine—ulcerative colitis	0.000579	0.00809	CcSEcCtD
Ruxolitinib—Weight increased—Budesonide—ulcerative colitis	0.00056	0.00783	CcSEcCtD
Ruxolitinib—MAP3K3—liver—ulcerative colitis	0.000559	0.00567	CbGeAlD
Ruxolitinib—Contusion—Dexamethasone—ulcerative colitis	0.000555	0.00776	CcSEcCtD
Ruxolitinib—Contusion—Betamethasone—ulcerative colitis	0.000555	0.00776	CcSEcCtD
Ruxolitinib—Infestation NOS—Budesonide—ulcerative colitis	0.000549	0.00767	CcSEcCtD
Ruxolitinib—Infestation—Budesonide—ulcerative colitis	0.000549	0.00767	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—ulcerative colitis	0.000543	0.00759	CcSEcCtD
Ruxolitinib—Urinary tract infection—Budesonide—ulcerative colitis	0.000533	0.00745	CcSEcCtD
Ruxolitinib—Haematuria—Budesonide—ulcerative colitis	0.000523	0.00731	CcSEcCtD
Ruxolitinib—Pancytopenia—Azathioprine—ulcerative colitis	0.000522	0.00729	CcSEcCtD
Ruxolitinib—Epistaxis—Budesonide—ulcerative colitis	0.000518	0.00723	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Mercaptopurine—ulcerative colitis	0.000513	0.00717	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Mesalazine—ulcerative colitis	0.000511	0.00714	CcSEcCtD
Ruxolitinib—TAOK3—liver—ulcerative colitis	0.00051	0.00517	CbGeAlD
Ruxolitinib—Skin disorder—Mercaptopurine—ulcerative colitis	0.000509	0.00712	CcSEcCtD
Ruxolitinib—Nervous system disorder—Nicotine—ulcerative colitis	0.000498	0.00696	CcSEcCtD
Ruxolitinib—Haemoglobin—Budesonide—ulcerative colitis	0.000495	0.00692	CcSEcCtD
Ruxolitinib—Haemorrhage—Budesonide—ulcerative colitis	0.000493	0.00688	CcSEcCtD
Ruxolitinib—Infestation NOS—Azathioprine—ulcerative colitis	0.00049	0.00685	CcSEcCtD
Ruxolitinib—Infestation—Azathioprine—ulcerative colitis	0.00049	0.00685	CcSEcCtD
Ruxolitinib—Contusion—Prednisone—ulcerative colitis	0.000484	0.00676	CcSEcCtD
Ruxolitinib—Pancytopenia—Mesalazine—ulcerative colitis	0.000475	0.00664	CcSEcCtD
Ruxolitinib—Neutropenia—Mesalazine—ulcerative colitis	0.000468	0.00654	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Azathioprine—ulcerative colitis	0.000463	0.00647	CcSEcCtD
Ruxolitinib—Weight increased—Mesalazine—ulcerative colitis	0.000455	0.00636	CcSEcCtD
Ruxolitinib—Weight decreased—Mesalazine—ulcerative colitis	0.000453	0.00633	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Mercaptopurine—ulcerative colitis	0.000453	0.00633	CcSEcCtD
Ruxolitinib—Infestation NOS—Mesalazine—ulcerative colitis	0.000446	0.00624	CcSEcCtD
Ruxolitinib—Infestation—Mesalazine—ulcerative colitis	0.000446	0.00624	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Prednisone—ulcerative colitis	0.000446	0.00624	CcSEcCtD
Ruxolitinib—Haemoglobin—Azathioprine—ulcerative colitis	0.000442	0.00618	CcSEcCtD
Ruxolitinib—Haemorrhage—Azathioprine—ulcerative colitis	0.00044	0.00615	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000439	0.00613	CcSEcCtD
Ruxolitinib—Fatigue—Nicotine—ulcerative colitis	0.000438	0.00612	CcSEcCtD
Ruxolitinib—Urinary tract infection—Mesalazine—ulcerative colitis	0.000434	0.00606	CcSEcCtD
Ruxolitinib—Malnutrition—Budesonide—ulcerative colitis	0.000429	0.00599	CcSEcCtD
Ruxolitinib—Haematuria—Mesalazine—ulcerative colitis	0.000425	0.00595	CcSEcCtD
Ruxolitinib—Flatulence—Budesonide—ulcerative colitis	0.000423	0.0059	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Mesalazine—ulcerative colitis	0.000422	0.0059	CcSEcCtD
Ruxolitinib—Epistaxis—Mesalazine—ulcerative colitis	0.000421	0.00588	CcSEcCtD
Ruxolitinib—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000415	0.00579	CcSEcCtD
Ruxolitinib—Haemoglobin—Mesalazine—ulcerative colitis	0.000403	0.00563	CcSEcCtD
Ruxolitinib—Body temperature increased—Nicotine—ulcerative colitis	0.000402	0.00561	CcSEcCtD
Ruxolitinib—Haemorrhage—Mesalazine—ulcerative colitis	0.000401	0.0056	CcSEcCtD
Ruxolitinib—Anaemia—Budesonide—ulcerative colitis	0.000396	0.00554	CcSEcCtD
Ruxolitinib—Asthenia—Nicotine—ulcerative colitis	0.000365	0.00509	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Hydrocortisone—ulcerative colitis	0.000363	0.00507	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000363	0.00507	CcSEcCtD
Ruxolitinib—Pruritus—Nicotine—ulcerative colitis	0.00036	0.00502	CcSEcCtD
Ruxolitinib—Anaemia—Azathioprine—ulcerative colitis	0.000354	0.00494	CcSEcCtD
Ruxolitinib—Infection—Budesonide—ulcerative colitis	0.000348	0.00486	CcSEcCtD
Ruxolitinib—Flatulence—Mesalazine—ulcerative colitis	0.000344	0.0048	CcSEcCtD
Ruxolitinib—Nervous system disorder—Budesonide—ulcerative colitis	0.000343	0.0048	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Methylprednisolone—ulcerative colitis	0.000341	0.00477	CcSEcCtD
Ruxolitinib—Skin disorder—Budesonide—ulcerative colitis	0.00034	0.00475	CcSEcCtD
Ruxolitinib—Dizziness—Nicotine—ulcerative colitis	0.000336	0.0047	CcSEcCtD
Ruxolitinib—Weight increased—Prednisolone—ulcerative colitis	0.000332	0.00463	CcSEcCtD
Ruxolitinib—Weight increased—Hydrocortisone—ulcerative colitis	0.000324	0.00453	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000324	0.00452	CcSEcCtD
Ruxolitinib—Anaemia—Mesalazine—ulcerative colitis	0.000322	0.0045	CcSEcCtD
Ruxolitinib—Weight decreased—Hydrocortisone—ulcerative colitis	0.000322	0.0045	CcSEcCtD
Ruxolitinib—Headache—Nicotine—ulcerative colitis	0.000318	0.00445	CcSEcCtD
Ruxolitinib—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000317	0.00443	CcSEcCtD
Ruxolitinib—Infestation—Hydrocortisone—ulcerative colitis	0.000317	0.00443	CcSEcCtD
Ruxolitinib—Infection—Azathioprine—ulcerative colitis	0.00031	0.00434	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Prednisone—ulcerative colitis	0.000306	0.00428	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000306	0.00427	CcSEcCtD
Ruxolitinib—Weight increased—Triamcinolone—ulcerative colitis	0.000305	0.00426	CcSEcCtD
Ruxolitinib—Weight increased—Methylprednisolone—ulcerative colitis	0.000304	0.00425	CcSEcCtD
Ruxolitinib—Skin disorder—Azathioprine—ulcerative colitis	0.000303	0.00424	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000302	0.00422	CcSEcCtD
Ruxolitinib—Fatigue—Budesonide—ulcerative colitis	0.000302	0.00422	CcSEcCtD
Ruxolitinib—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000298	0.00417	CcSEcCtD
Ruxolitinib—Infestation—Methylprednisolone—ulcerative colitis	0.000298	0.00417	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000295	0.00412	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisolone—ulcerative colitis	0.000293	0.0041	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisolone—ulcerative colitis	0.000292	0.00408	CcSEcCtD
Ruxolitinib—Haemoglobin—Hydrocortisone—ulcerative colitis	0.000286	0.004	CcSEcCtD
Ruxolitinib—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000285	0.00398	CcSEcCtD
Ruxolitinib—Infection—Mesalazine—ulcerative colitis	0.000283	0.00395	CcSEcCtD
Ruxolitinib—Epistaxis—Triamcinolone—ulcerative colitis	0.000282	0.00394	CcSEcCtD
Ruxolitinib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000279	0.0039	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000279	0.00389	CcSEcCtD
Ruxolitinib—Weight increased—Dexamethasone—ulcerative colitis	0.000277	0.00387	CcSEcCtD
Ruxolitinib—Weight increased—Betamethasone—ulcerative colitis	0.000277	0.00387	CcSEcCtD
Ruxolitinib—Body temperature increased—Budesonide—ulcerative colitis	0.000277	0.00387	CcSEcCtD
Ruxolitinib—Skin disorder—Mesalazine—ulcerative colitis	0.000276	0.00386	CcSEcCtD
Ruxolitinib—Weight decreased—Betamethasone—ulcerative colitis	0.000275	0.00384	CcSEcCtD
Ruxolitinib—Weight decreased—Dexamethasone—ulcerative colitis	0.000275	0.00384	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.00027	0.00378	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00027	0.00377	CcSEcCtD
Ruxolitinib—Haemoglobin—Triamcinolone—ulcerative colitis	0.00027	0.00377	CcSEcCtD
Ruxolitinib—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000269	0.00376	CcSEcCtD
Ruxolitinib—Haemorrhage—Triamcinolone—ulcerative colitis	0.000268	0.00375	CcSEcCtD
Ruxolitinib—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000268	0.00374	CcSEcCtD
Ruxolitinib—Asthenia—Budesonide—ulcerative colitis	0.000251	0.00351	CcSEcCtD
Ruxolitinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000248	0.00346	CcSEcCtD
Ruxolitinib—Neutropenia—Prednisone—ulcerative colitis	0.000248	0.00346	CcSEcCtD
Ruxolitinib—Pruritus—Budesonide—ulcerative colitis	0.000248	0.00346	CcSEcCtD
Ruxolitinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000247	0.00345	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000246	0.00343	CcSEcCtD
Ruxolitinib—Fatigue—Mesalazine—ulcerative colitis	0.000245	0.00343	CcSEcCtD
Ruxolitinib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000245	0.00342	CcSEcCtD
Ruxolitinib—Haemoglobin—Betamethasone—ulcerative colitis	0.000245	0.00342	CcSEcCtD
Ruxolitinib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000243	0.0034	CcSEcCtD
Ruxolitinib—Haemorrhage—Betamethasone—ulcerative colitis	0.000243	0.0034	CcSEcCtD
Ruxolitinib—Weight increased—Prednisone—ulcerative colitis	0.000241	0.00337	CcSEcCtD
Ruxolitinib—Weight decreased—Prednisone—ulcerative colitis	0.00024	0.00335	CcSEcCtD
Ruxolitinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000233	0.00326	CcSEcCtD
Ruxolitinib—Dizziness—Budesonide—ulcerative colitis	0.000231	0.00323	CcSEcCtD
Ruxolitinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000225	0.00314	CcSEcCtD
Ruxolitinib—Headache—Budesonide—ulcerative colitis	0.000219	0.00306	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisone—ulcerative colitis	0.000213	0.00298	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisone—ulcerative colitis	0.000212	0.00296	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00021	0.00293	CcSEcCtD
Ruxolitinib—CYP3A4—digestive system—ulcerative colitis	0.000208	0.00211	CbGeAlD
Ruxolitinib—Dizziness—Azathioprine—ulcerative colitis	0.000207	0.00289	CcSEcCtD
Ruxolitinib—Asthenia—Mesalazine—ulcerative colitis	0.000204	0.00285	CcSEcCtD
Ruxolitinib—Pruritus—Mesalazine—ulcerative colitis	0.000201	0.00281	CcSEcCtD
Ruxolitinib—Infection—Hydrocortisone—ulcerative colitis	0.000201	0.00281	CcSEcCtD
Ruxolitinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000198	0.00277	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000197	0.00275	CcSEcCtD
Ruxolitinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000197	0.00275	CcSEcCtD
Ruxolitinib—Headache—Azathioprine—ulcerative colitis	0.000196	0.00274	CcSEcCtD
Ruxolitinib—Infection—Triamcinolone—ulcerative colitis	0.000189	0.00265	CcSEcCtD
Ruxolitinib—Infection—Methylprednisolone—ulcerative colitis	0.000189	0.00264	CcSEcCtD
Ruxolitinib—Dizziness—Mesalazine—ulcerative colitis	0.000188	0.00263	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000186	0.00261	CcSEcCtD
Ruxolitinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000185	0.00258	CcSEcCtD
Ruxolitinib—Malnutrition—Prednisone—ulcerative colitis	0.000185	0.00258	CcSEcCtD
Ruxolitinib—Headache—Mesalazine—ulcerative colitis	0.000178	0.00249	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000175	0.00244	CcSEcCtD
Ruxolitinib—Fatigue—Hydrocortisone—ulcerative colitis	0.000174	0.00244	CcSEcCtD
Ruxolitinib—Infection—Dexamethasone—ulcerative colitis	0.000172	0.0024	CcSEcCtD
Ruxolitinib—Infection—Betamethasone—ulcerative colitis	0.000172	0.0024	CcSEcCtD
Ruxolitinib—Anaemia—Prednisone—ulcerative colitis	0.000171	0.00238	CcSEcCtD
Ruxolitinib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.00017	0.00237	CcSEcCtD
Ruxolitinib—Nervous system disorder—Betamethasone—ulcerative colitis	0.00017	0.00237	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000169	0.00237	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000169	0.00237	CcSEcCtD
Ruxolitinib—Fatigue—Triamcinolone—ulcerative colitis	0.000164	0.0023	CcSEcCtD
Ruxolitinib—Fatigue—Methylprednisolone—ulcerative colitis	0.000164	0.00229	CcSEcCtD
Ruxolitinib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00016	0.00224	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000156	0.00218	CcSEcCtD
Ruxolitinib—CYP3A4—liver—ulcerative colitis	0.000155	0.00157	CbGeAlD
Ruxolitinib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000151	0.0021	CcSEcCtD
Ruxolitinib—Infection—Prednisone—ulcerative colitis	0.00015	0.00209	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000149	0.00209	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000149	0.00209	CcSEcCtD
Ruxolitinib—Fatigue—Dexamethasone—ulcerative colitis	0.000149	0.00208	CcSEcCtD
Ruxolitinib—Fatigue—Betamethasone—ulcerative colitis	0.000149	0.00208	CcSEcCtD
Ruxolitinib—Nervous system disorder—Prednisone—ulcerative colitis	0.000148	0.00206	CcSEcCtD
Ruxolitinib—Skin disorder—Prednisone—ulcerative colitis	0.000146	0.00204	CcSEcCtD
Ruxolitinib—Asthenia—Hydrocortisone—ulcerative colitis	0.000145	0.00203	CcSEcCtD
Ruxolitinib—Pruritus—Hydrocortisone—ulcerative colitis	0.000143	0.002	CcSEcCtD
Ruxolitinib—Dizziness—Prednisolone—ulcerative colitis	0.000137	0.00191	CcSEcCtD
Ruxolitinib—Asthenia—Triamcinolone—ulcerative colitis	0.000137	0.00191	CcSEcCtD
Ruxolitinib—Body temperature increased—Dexamethasone—ulcerative colitis	0.000137	0.00191	CcSEcCtD
Ruxolitinib—Body temperature increased—Betamethasone—ulcerative colitis	0.000137	0.00191	CcSEcCtD
Ruxolitinib—Asthenia—Methylprednisolone—ulcerative colitis	0.000136	0.00191	CcSEcCtD
Ruxolitinib—Pruritus—Triamcinolone—ulcerative colitis	0.000135	0.00188	CcSEcCtD
Ruxolitinib—Pruritus—Methylprednisolone—ulcerative colitis	0.000135	0.00188	CcSEcCtD
Ruxolitinib—Dizziness—Hydrocortisone—ulcerative colitis	0.000134	0.00187	CcSEcCtD
Ruxolitinib—Fatigue—Prednisone—ulcerative colitis	0.00013	0.00181	CcSEcCtD
Ruxolitinib—Headache—Prednisolone—ulcerative colitis	0.00013	0.00181	CcSEcCtD
Ruxolitinib—Headache—Hydrocortisone—ulcerative colitis	0.000127	0.00177	CcSEcCtD
Ruxolitinib—Dizziness—Triamcinolone—ulcerative colitis	0.000126	0.00176	CcSEcCtD
Ruxolitinib—Dizziness—Methylprednisolone—ulcerative colitis	0.000126	0.00176	CcSEcCtD
Ruxolitinib—Asthenia—Betamethasone—ulcerative colitis	0.000124	0.00173	CcSEcCtD
Ruxolitinib—Asthenia—Dexamethasone—ulcerative colitis	0.000124	0.00173	CcSEcCtD
Ruxolitinib—Pruritus—Dexamethasone—ulcerative colitis	0.000122	0.00171	CcSEcCtD
Ruxolitinib—Pruritus—Betamethasone—ulcerative colitis	0.000122	0.00171	CcSEcCtD
Ruxolitinib—Headache—Triamcinolone—ulcerative colitis	0.000119	0.00167	CcSEcCtD
Ruxolitinib—Headache—Methylprednisolone—ulcerative colitis	0.000119	0.00166	CcSEcCtD
Ruxolitinib—Body temperature increased—Prednisone—ulcerative colitis	0.000119	0.00166	CcSEcCtD
Ruxolitinib—Dizziness—Dexamethasone—ulcerative colitis	0.000114	0.0016	CcSEcCtD
Ruxolitinib—Dizziness—Betamethasone—ulcerative colitis	0.000114	0.0016	CcSEcCtD
Ruxolitinib—Headache—Betamethasone—ulcerative colitis	0.000108	0.00151	CcSEcCtD
Ruxolitinib—Headache—Dexamethasone—ulcerative colitis	0.000108	0.00151	CcSEcCtD
Ruxolitinib—Asthenia—Prednisone—ulcerative colitis	0.000108	0.00151	CcSEcCtD
Ruxolitinib—Pruritus—Prednisone—ulcerative colitis	0.000107	0.00149	CcSEcCtD
Ruxolitinib—Dizziness—Prednisone—ulcerative colitis	9.96e-05	0.00139	CcSEcCtD
Ruxolitinib—Headache—Prednisone—ulcerative colitis	9.43e-05	0.00132	CcSEcCtD
Ruxolitinib—JAK3—Immune System—IL1B—ulcerative colitis	7.03e-06	3.18e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL2—ulcerative colitis	7e-06	3.17e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—STAT3—ulcerative colitis	6.98e-06	3.16e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RIPK2—ulcerative colitis	6.96e-06	3.15e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—STAT3—ulcerative colitis	6.95e-06	3.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—NFKB1—ulcerative colitis	6.95e-06	3.15e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CRP—ulcerative colitis	6.94e-06	3.14e-05	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—IL6—ulcerative colitis	6.93e-06	3.14e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—NFKB1—ulcerative colitis	6.93e-06	3.14e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—JAK2—ulcerative colitis	6.91e-06	3.13e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—CXCL8—ulcerative colitis	6.9e-06	3.12e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—IL6—ulcerative colitis	6.88e-06	3.12e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—TLR4—ulcerative colitis	6.86e-06	3.11e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HLA-DRB1—ulcerative colitis	6.85e-06	3.1e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—CXCL8—ulcerative colitis	6.78e-06	3.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—ADCY5—ulcerative colitis	6.78e-06	3.07e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IFNG—ulcerative colitis	6.78e-06	3.07e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—ICAM1—ulcerative colitis	6.77e-06	3.07e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—IL6—ulcerative colitis	6.77e-06	3.07e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TGFB1—ulcerative colitis	6.74e-06	3.05e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAML2—ulcerative colitis	6.71e-06	3.04e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—RELA—ulcerative colitis	6.69e-06	3.03e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—NFKB1—ulcerative colitis	6.66e-06	3.02e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TLR4—ulcerative colitis	6.65e-06	3.01e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HLA-DRB1—ulcerative colitis	6.65e-06	3.01e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL2—ulcerative colitis	6.59e-06	2.99e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—ICAM1—ulcerative colitis	6.58e-06	2.98e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—NFKB1—ulcerative colitis	6.56e-06	2.97e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CD4—ulcerative colitis	6.55e-06	2.97e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL2—ulcerative colitis	6.48e-06	2.94e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—STAT3—ulcerative colitis	6.45e-06	2.92e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TGFB1—ulcerative colitis	6.44e-06	2.92e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IL2—ulcerative colitis	6.43e-06	2.91e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—RELA—ulcerative colitis	6.42e-06	2.91e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ADRB2—ulcerative colitis	6.42e-06	2.91e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—STAT3—ulcerative colitis	6.39e-06	2.9e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—ICAM1—ulcerative colitis	6.38e-06	2.89e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—JAK2—ulcerative colitis	6.38e-06	2.89e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—ulcerative colitis	6.3e-06	2.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—CD4—ulcerative colitis	6.29e-06	2.85e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—STAT3—ulcerative colitis	6.25e-06	2.83e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—TP53—ulcerative colitis	6.24e-06	2.83e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTGER4—ulcerative colitis	6.23e-06	2.82e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ADRB2—ulcerative colitis	6.23e-06	2.82e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MMP9—ulcerative colitis	6.2e-06	2.81e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ADCY5—ulcerative colitis	6.2e-06	2.81e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—JAK2—ulcerative colitis	6.15e-06	2.79e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—NFKB1—ulcerative colitis	6.13e-06	2.78e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—IL6—ulcerative colitis	6.08e-06	2.75e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—IL6—ulcerative colitis	6.06e-06	2.75e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL1B—ulcerative colitis	6.05e-06	2.74e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—CD4—ulcerative colitis	6.04e-06	2.74e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ADRB2—ulcerative colitis	6.04e-06	2.74e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL2—ulcerative colitis	6.02e-06	2.73e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PTGS2—ulcerative colitis	6e-06	2.72e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CDH1—ulcerative colitis	5.99e-06	2.71e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—TGFB1—ulcerative colitis	5.97e-06	2.71e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—IL6—ulcerative colitis	5.96e-06	2.7e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—RELA—ulcerative colitis	5.96e-06	2.7e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—STAT3—ulcerative colitis	5.89e-06	2.67e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TP53—ulcerative colitis	5.87e-06	2.66e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CDH1—ulcerative colitis	5.82e-06	2.63e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—ADCY5—ulcerative colitis	5.72e-06	2.59e-05	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IL6—ulcerative colitis	5.71e-06	2.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—GHRL—ulcerative colitis	5.7e-06	2.58e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CDH1—ulcerative colitis	5.64e-06	2.55e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—NFKB1—ulcerative colitis	5.64e-06	2.55e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CXCL8—ulcerative colitis	5.61e-06	2.54e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—JAK2—ulcerative colitis	5.58e-06	2.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CALM3—ulcerative colitis	5.52e-06	2.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—STAT3—ulcerative colitis	5.51e-06	2.5e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ADCY5—ulcerative colitis	5.45e-06	2.47e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RIPK2—ulcerative colitis	5.44e-06	2.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CRP—ulcerative colitis	5.42e-06	2.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—NFKB1—ulcerative colitis	5.42e-06	2.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—IL6—ulcerative colitis	5.4e-06	2.44e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL6—ulcerative colitis	5.37e-06	2.43e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—ulcerative colitis	5.36e-06	2.43e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—ulcerative colitis	5.34e-06	2.42e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TP53—ulcerative colitis	5.31e-06	2.4e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ADCY5—ulcerative colitis	5.29e-06	2.39e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—JAK2—ulcerative colitis	5.25e-06	2.38e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TLR4—ulcerative colitis	5.2e-06	2.35e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DRB1—ulcerative colitis	5.19e-06	2.35e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—JAK2—ulcerative colitis	5.19e-06	2.35e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—ulcerative colitis	5.15e-06	2.33e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ADCY5—ulcerative colitis	5.13e-06	2.32e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TGFB1—ulcerative colitis	5.11e-06	2.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—JAK2—ulcerative colitis	5.1e-06	2.31e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CXCL8—ulcerative colitis	5.09e-06	2.31e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—RELA—ulcerative colitis	5.09e-06	2.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—ulcerative colitis	5.08e-06	2.3e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—ulcerative colitis	5.08e-06	2.3e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—STAT3—ulcerative colitis	5.07e-06	2.3e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—RELA—ulcerative colitis	5.03e-06	2.28e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NFKB1—ulcerative colitis	5.02e-06	2.28e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TGFB1—ulcerative colitis	5.01e-06	2.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—ulcerative colitis	5e-06	2.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ICAM1—ulcerative colitis	4.98e-06	2.26e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—ulcerative colitis	4.98e-06	2.25e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.97e-06	2.25e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—JAK2—ulcerative colitis	4.94e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—RELA—ulcerative colitis	4.94e-06	2.24e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—ulcerative colitis	4.88e-06	2.21e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—ulcerative colitis	4.87e-06	2.2e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—ulcerative colitis	4.86e-06	2.2e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—ulcerative colitis	4.85e-06	2.2e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—ulcerative colitis	4.83e-06	2.19e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—RELA—ulcerative colitis	4.79e-06	2.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—ulcerative colitis	4.77e-06	2.16e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CXCL8—ulcerative colitis	4.74e-06	2.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADRB2—ulcerative colitis	4.72e-06	2.14e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—JAK2—ulcerative colitis	4.71e-06	2.13e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—ulcerative colitis	4.69e-06	2.12e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—STAT3—ulcerative colitis	4.68e-06	2.12e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—ulcerative colitis	4.62e-06	2.09e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—ulcerative colitis	4.6e-06	2.08e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—ulcerative colitis	4.58e-06	2.07e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—ulcerative colitis	4.53e-06	2.05e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—STAT3—ulcerative colitis	4.51e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—ulcerative colitis	4.5e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—ulcerative colitis	4.5e-06	2.04e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—ulcerative colitis	4.49e-06	2.03e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—ulcerative colitis	4.47e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—JAK2—ulcerative colitis	4.46e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—ulcerative colitis	4.46e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—ulcerative colitis	4.46e-06	2.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—ulcerative colitis	4.45e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—ulcerative colitis	4.43e-06	2.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CDH1—ulcerative colitis	4.41e-06	2e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—JAK2—ulcerative colitis	4.39e-06	1.99e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—ulcerative colitis	4.36e-06	1.98e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—ulcerative colitis	4.35e-06	1.97e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—ulcerative colitis	4.34e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—ulcerative colitis	4.33e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—RELA—ulcerative colitis	4.32e-06	1.96e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—ulcerative colitis	4.31e-06	1.95e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NFKB1—ulcerative colitis	4.29e-06	1.94e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DLD—ulcerative colitis	4.29e-06	1.94e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—ulcerative colitis	4.28e-06	1.94e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—RELA—ulcerative colitis	4.25e-06	1.93e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CXCL8—ulcerative colitis	4.25e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NFKB1—ulcerative colitis	4.24e-06	1.92e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—ulcerative colitis	4.18e-06	1.9e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NFKB1—ulcerative colitis	4.16e-06	1.89e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TP53—ulcerative colitis	4.13e-06	1.87e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—ulcerative colitis	4.12e-06	1.86e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CXCL8—ulcerative colitis	4.07e-06	1.85e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—ulcerative colitis	4.06e-06	1.84e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NFKB1—ulcerative colitis	4.04e-06	1.83e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CXCL8—ulcerative colitis	4.01e-06	1.82e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADCY5—ulcerative colitis	4.01e-06	1.81e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—ulcerative colitis	3.89e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—ulcerative colitis	3.87e-06	1.76e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CXCL8—ulcerative colitis	3.86e-06	1.75e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—STAT3—ulcerative colitis	3.85e-06	1.75e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—ulcerative colitis	3.85e-06	1.74e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—ulcerative colitis	3.83e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—ulcerative colitis	3.81e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—STAT3—ulcerative colitis	3.81e-06	1.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—ulcerative colitis	3.79e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—RELA—ulcerative colitis	3.74e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—STAT3—ulcerative colitis	3.74e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—ulcerative colitis	3.69e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—ulcerative colitis	3.69e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—ulcerative colitis	3.66e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NFKB1—ulcerative colitis	3.65e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—STAT3—ulcerative colitis	3.63e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—ulcerative colitis	3.63e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NFKB1—ulcerative colitis	3.59e-06	1.62e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—ulcerative colitis	3.54e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—ulcerative colitis	3.53e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—STAT3—ulcerative colitis	3.45e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—ulcerative colitis	3.44e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—ulcerative colitis	3.4e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—JAK2—ulcerative colitis	3.4e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—ulcerative colitis	3.38e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—ulcerative colitis	3.38e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—ulcerative colitis	3.37e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—ulcerative colitis	3.36e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—JAK2—ulcerative colitis	3.3e-06	1.49e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RELA—ulcerative colitis	3.29e-06	1.49e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—STAT3—ulcerative colitis	3.28e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—ulcerative colitis	3.27e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—STAT3—ulcerative colitis	3.22e-06	1.46e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—ulcerative colitis	3.2e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—JAK2—ulcerative colitis	3.2e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RELA—ulcerative colitis	3.19e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NFKB1—ulcerative colitis	3.16e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—ulcerative colitis	3.15e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CXCL8—ulcerative colitis	3.1e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RELA—ulcerative colitis	3.1e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—ulcerative colitis	3.04e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL8—ulcerative colitis	3.01e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—ulcerative colitis	2.99e-06	1.35e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—ulcerative colitis	2.96e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL8—ulcerative colitis	2.92e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—ulcerative colitis	2.91e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—ulcerative colitis	2.87e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—ulcerative colitis	2.86e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—STAT3—ulcerative colitis	2.84e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—ulcerative colitis	2.8e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—ulcerative colitis	2.79e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NFKB1—ulcerative colitis	2.77e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—ulcerative colitis	2.72e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—ulcerative colitis	2.69e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NFKB1—ulcerative colitis	2.69e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—ulcerative colitis	2.66e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—ulcerative colitis	2.64e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—STAT3—ulcerative colitis	2.62e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—ulcerative colitis	2.61e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NFKB1—ulcerative colitis	2.61e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—ulcerative colitis	2.54e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—ulcerative colitis	2.5e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—STAT3—ulcerative colitis	2.49e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—ulcerative colitis	2.46e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—ulcerative colitis	2.43e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RELA—ulcerative colitis	2.42e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—STAT3—ulcerative colitis	2.42e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—ulcerative colitis	2.41e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—STAT3—ulcerative colitis	2.35e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—ulcerative colitis	2.31e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—ulcerative colitis	2.29e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL8—ulcerative colitis	2.28e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—ulcerative colitis	2.25e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—ulcerative colitis	2.24e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—ulcerative colitis	2.18e-06	9.87e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—ulcerative colitis	2.18e-06	9.85e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—ulcerative colitis	2.17e-06	9.82e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.07e-06	9.39e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—ulcerative colitis	2.06e-06	9.34e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NFKB1—ulcerative colitis	2.04e-06	9.24e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—ulcerative colitis	1.98e-06	8.97e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—ulcerative colitis	1.9e-06	8.61e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.87e-06	8.46e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—ulcerative colitis	1.85e-06	8.36e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—STAT3—ulcerative colitis	1.83e-06	8.3e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—ulcerative colitis	1.83e-06	8.28e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—ulcerative colitis	1.79e-06	8.11e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—ulcerative colitis	1.74e-06	7.88e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—ulcerative colitis	1.7e-06	7.7e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—ulcerative colitis	1.69e-06	7.65e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—ulcerative colitis	1.64e-06	7.42e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.45e-06	6.58e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—ulcerative colitis	1.4e-06	6.34e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.35e-06	6.13e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—ulcerative colitis	1.28e-06	5.8e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.01e-06	4.57e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALB—ulcerative colitis	9.08e-07	4.11e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.95e-07	3.6e-06	CbGpPWpGaD
